SAN FRANCISCO--(BUSINESS WIRE)--VIA Pharmaceuticals (Nasdaq: VIAP) a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, today announced that Lawrence Cohen, Chief Executive Officer of VIA, will present a company update at The Noble Financial Two Double-0-Seven Small-Cap Conference and Micro-Cap Symposium in Charleston, SC on Tuesday, August 21, 2007 at 12:00 p.m. ET.
